Patients with blood cancers are more vulnerable to the COVID-19 virus than those with solid tumours, according to a major analysis. The study will help build a much-needed picture of cancer-specific infection and immunity to su...
5 months ago
A commonly used cancer drug could be used to create a molecular on-off switch to regulate the activity of CAR-T cells, US researchers have reported. CAR-T cells effectively target blood cancers but they can grow rapidly over we...
5 months ago